Oops, who you gonna call?

So, in a move to greatly increase the number of people who can get at least one dose of a coronavirus vaccine, Health Canada has approved the use of the AstraZeneca coronavirus vaccine for all adults, including those over the age of 65, which is based on the experience of countries that are using that strategy, such as the UK, and which have reported excellent data about the use of this vaccine in seniors.

However, the National Advisory Committee on Immunizations (NACI), who are mostly people working in ivory towers, has recommended against using the AstraZeneca-Oxford vaccine in people aged 65 and older because there is just not enough supporting data, these experts say, from the pre-approval trials about using that vaccine in seniors.

So, who you gonna believe?

I think this one is easy: In most circumstances, you just can’t argue with real-world data.